2020 News - Pancreatic Cancer Canada

2020 News Archive

PCC Board Chair Dr. Anish Kirpalani talks about awareness, research and his personal connection to pancreatic cancer: The Health and Wellness Show with Dr. Mike Wahl

PCC Board Chair Dr. Anish Kirpalani talks about awareness, research and his personal connection to pancreatic cancer: The Health and Wellness Show with Dr. Mike Wahl Pancreatic Cancer Canada Chair Dr. Anish Kirpalani speaks with Dr. Mike Wahl about pancreatic cancer...

Alex Trebek’s Death and the Need for Research

Alex Trebek's Death and the Need for Innovative Research: 900CHML Pancreatic Cancer Canada CEO Michelle Capobianco speaks with 900CHML host Scott Thompson about Alex Trebek's passing to stage IV pancreatic cancer, the need for public awareness and understanding of the...

Access to Pancreatic Cancer Treatments Newstalk 1010

Access to Pancreatic Cancer Treatments: Pancreatic Cancer Canada CEO Michelle Capobianco Speaks to Newstalk 1010 Michelle Capobianco, Chief Executive Officer of Pancreatic Cancer Canada, speaks with John Moore of Newstalk 1010 about the bureaucracy that prevents new...

Promising Treatment for Deadly Cancer Blocked by Canadian Regulators

Promising Treatment for Deadly Cancer Blocked by Canadian Regulators TORONTO, Aug. 19, 2020 /CNW Telbec/ - While innovations in health care are spurring extraordinary advances in the treatment of malignant tumours, progress has been limited when it comes to the...

NeoPancONE Announcement: A Message from Michelle Capobianco

For several months the COVID-19 crisis has caused many research projects to slow, but Pancreatic Cancer Canada's research program has not been idle. We have taken this time to quietly prepare for our next big project, because even in the midst of a...

PRESS RELEASE: NeoPancONE Clinical Trial Launch

Pancreatic Cancer Clinical Trial Launches During Pandemic With Aim to Change Standard of Care for Patients TORONTO, ON, July 15, 2020 – Pancreatic Cancer Canada announced today the launch of NeoPancONE, a Phase II clinical trial that aims to be a curative strategy for...